Belgium vs Mongolia: Proportion of isolates with decreased susceptibility or resistance
Belgium
0.6
in 2020
Mongolia
0.7752
in 2018
Belgium rank
10th
Mongolia rank
9th
Proportion of isolates with decreased susceptibility or resistance over time
- Belgium
- Mongolia
How they compare
Mongolia currently reports 0.7752 against 0.6 in Belgium, a difference of 0.1752.
That makes Mongolia's figure about 1.3 times Belgium's.
Across all 6 years both countries report, Mongolia has been ahead every year.
Belgium ranks 10th and Mongolia ranks 9th of 52 countries.
Mongolia has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Belgium | Mongolia | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0 | 19.13 | 19.13 | Mongolia |
| 2010s | 0 | 11.33 | 11.33 | Mongolia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of isolates with decreased susceptibility or resistance, Belgium or Mongolia?
- Mongolia, at 0.7752 against 0.6 in Belgium as of 2018.
- What is the difference in proportion of isolates with decreased susceptibility or resistance between Belgium and Mongolia?
- 0.1752, with Mongolia ahead.
- How many years of comparable data are there for Belgium and Mongolia?
- 6 years are reported by both, from 2009 to 2018.
- How do Belgium and Mongolia rank globally for proportion of isolates with decreased susceptibility or resistance?
- Belgium ranks 10th and Mongolia ranks 9th of 52 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Proportion of isolates with decreased susceptibility or resistance (DS/R) to ceftriaxone reported to WHO-GASP. Statizoid refreshes it automatically from the source and publishes the full history for both places.